Thanks to a freshly issued FDA approval, W. L. Gore & Associates will be bringing its Conformable GORE TAG Thoracic Endoprosthesis to the U.S. market. The device is designed for young patients when addressing isolated lesions of the thoracic aorta and can even be used for life threatening traumatic transections of the aorta, which till now required a fully open thoracic approach.
The Conformable GORE TAG Device is the only FDA approved thoracic endoprosthesis specifically designed to treat the anatomy of young trauma patients, with the ability to treat down to 16 mm aortas and extremely tapered anatomy. The device offers conformability and ease of use, while accommodating tapered anatomy and resisting compression. The broad oversizing window for the device ranges from 6 to 33 percent, allowing physicians to choose the appropriate oversizing for the patient anatomy.
The Conformable GORE TAG Thoracic Endoprosthesis is delivered via catheter and inserted into the femoral artery through a small incision in the groin and carefully guided up the leg artery through the abdomen into the chest and to the site of the transection. The device is available in diameters of 21-45 mm, allowing for the treatment of patients with aortic diameters of 16-42 mm. Tapered device configurations are also available.
Press release: Gore Receives First FDA Approval for Endovascular Repair of Traumatic Aortic Transections
Product page: GORE TAG…
